OMNIAB INC (OABI) Stock News

USA - Nasdaq - NASDAQ:OABI - US68218J1034 - Common Stock

1.74 USD

-0.07 (-3.87%)

Last: 12/1/2025, 8:00:02 PM

1.74 USD

0 (0%)

After Hours: 12/1/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

OABI Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Investor's Business Daily - Mentions: LGND RPRX TVTX MRK ...

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year

14 days ago - By: OmniAb, Inc.

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

a month ago - By: Zacks Investment Research - Mentions: DERM

OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates

a month ago - By: OmniAb, Inc.

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

a month ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

3 months ago - By: Benzinga - Mentions: NNOX ZTEK

Top 3 Health Care Stocks You'll Regret Missing This Quarter

a month ago - By: Zacks Investment Research - Mentions: NKTR

Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2 months ago - By: OmniAb, Inc.

OmniAb to Participate in Three Investor Conferences in November

2 months ago - By: OmniAb, Inc.

OmniAb to Report Third Quarter 2025 Financial Results on November 4

3 months ago - By: OmniAb, Inc.

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: OmniAb, Inc.

OmniAb Announces $30 Million Private Placement

4 months ago - By: Zacks Investment Research - Mentions: AKBA

OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue Estimates

4 months ago - By: OmniAb, Inc.

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

5 months ago - By: OmniAb, Inc.

OmniAb to Report Second Quarter 2025 Financial Results on August 6

7 months ago - By: OmniAb, Inc.

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

7 months ago - By: Zacks Investment Research - Mentions: ASRT

OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates

7 months ago - By: OmniAb, Inc.

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

7 months ago - By: OmniAb, Inc.

OmniAb Introduces the xPloration® Partner Access Program

7 months ago - By: OmniAb, Inc.

OmniAb to Participate in Five Upcoming Investor Conferences

7 months ago - By: OmniAb, Inc.

OmniAb Announces Two New Appointments to its Board of Directors

8 months ago - By: OmniAb, Inc.

OmniAb to Report First Quarter 2025 Financial Results on May 8

9 months ago - By: OmniAb, Inc.

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

9 months ago - By: OmniAb, Inc.

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

10 months ago - By: OmniAb, Inc.

OmniAb to Participate in Two Investor Conferences in March

10 months ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

a year ago - By: OmniAb, Inc.

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

a year ago - By: OmniAb, Inc.

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights